Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (16896)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 28, 2015 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Schlachterman A, Jr WWC, Hilgenfeldt E, Mitra A, Cabrera R. Current and future treatments for hepatocellular carcinoma. World J Gastroenterol 2015; 21(28): 8478-8491 [PMID: 26229392 DOI: 10.3748/wjg.v21.i28.8478] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v21/i28/8478.htm |
| Number | Citing Articles |
| 1 |
Lea Penzkofer, Tobias Huber, Jens Mittler, Hauke Lang, Stefan Heinrich. Leberresektionen können bei vorsichtiger Patientenselektion auch in Zirrhose sicher durchgeführt werden. Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie 2023; 148(02): 156 doi: 10.1055/a-1373-6218
|
| 2 |
Yu Zhang, Xiaofeng Zhang, Jinling Zhang, Bin Sun, Lulu Zheng, Jun Li, Sixiu Liu, Guodong Sui, Zhengfeng Yin. Microfluidic chip for isolation of viable circulating tumor cells of hepatocellular carcinoma for their culture and drug sensitivity assay. Cancer Biology & Therapy 2016; 17(11): 1177 doi: 10.1080/15384047.2016.1235665
|
| 3 |
M. Tampellini, A. La Salvia, G. V. Scagliotti. Novel investigational therapies for treating biliary tract carcinoma. Expert Opinion on Investigational Drugs 2016; 25(12): 1423 doi: 10.1080/13543784.2016.1252330
|
| 4 |
Jenny L. Firkins, Robin Tarter, Martha Driessnack, Lissi Hansen. A closer look at quality of life in the hepatocellular carcinoma literature. Quality of Life Research 2021; 30(6): 1525 doi: 10.1007/s11136-021-02789-2
|
| 5 |
Rossella Farra, Francesco Musiani, Francesca Perrone, Maja Čemažar, Urška Kamenšek, Federica Tonon, Michela Abrami, Aleš Ručigaj, Mario Grassi, Gabriele Pozzato, Deborah Bonazza, Fabrizio Zanconati, Giancarlo Forte, Maguie El Boustani, Lucia Scarabel, Marica Garziera, Concetta Russo Spena, Lucia De Stefano, Barbara Salis, Giuseppe Toffoli, Flavio Rizzolio, Gabriele Grassi, Barbara Dapas. Polymer-Mediated Delivery of siRNAs to Hepatocellular Carcinoma: Variables Affecting Specificity and Effectiveness. Molecules 2018; 23(4): 777 doi: 10.3390/molecules23040777
|
| 6 |
Yue Zhao, Timothy Wai Ho Shuen, Tan Boon Toh, Xue Ying Chan, Min Liu, Sue Yee Tan, Yong Fan, Hechuan Yang, Shridhar Ganpathi Lyer, Glenn Kunnath Bonney, Eva Loh, Kenneth Tou En Chang, Thiam Chye Tan, Weiwei Zhai, Jerry Kok Yen Chan, Edward Kai-Hua Chow, Cheng Ean Chee, Guan Huei Lee, Yock Young Dan, Pierce Kah-Hoe Chow, Han Chong Toh, Seng Gee Lim, Qingfeng Chen. Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy. Gut 2018; 67(10): 1845 doi: 10.1136/gutjnl-2017-315201
|
| 7 |
Gynura procumbens methanolic extracts suppresses proliferation of hepatocellular carcinoma: In vitro assay. THE 8TH INTERNATIONAL CONFERENCE AND WORKSHOP ON BASIC AND APPLIED SCIENCE (ICOWOBAS) 2021 2023; 2554: 090007 doi: 10.1063/5.0104809
|
| 8 |
Nianzhi Chen, Yulin Qi, Xiao Ma, Xiaolin Xiao, Qingsong Liu, Ting Xia, Juyi Xiang, Jinhao Zeng, Jianyuan Tang. Rediscovery of Traditional Plant Medicine: An Underestimated Anticancer Drug of Chelerythrine. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.906301
|
| 9 |
Yaning Wei, Yanan Wang, Aimin Zang, Yanhong Shang, Zizheng Song, Zhiyu Wang, Yangyang Wang, Hua Yang. Inducible T-cell co-stimulators regulate the proliferation and invasion of human hepatocellular carcinoma HepG2 cells. Biological Research 2018; 51(1) doi: 10.1186/s40659-017-0150-7
|
| 10 |
Hyun-Soo Kim, Eun-Ji Park, Chang-Woo Lee. Implication of hepatocyte dedifferentiation in pathogenesis and treatment of hepatocellular carcinoma. Precision and Future Medicine 2019; 3(2): 37 doi: 10.23838/pfm.2018.00135
|
| 11 |
Ling Yang, Mi-Na Jiang, Yang Liu, Chao-Qun Wu, Hong Liu. Crosstalk between lncRNA DANCR and miR-125b-5p in HCC cell progression. Tumori Journal 2021; 107(6): 504 doi: 10.1177/0300891620977010
|
| 12 |
Thomas Couri, Anjana Pillai. Goals and targets for personalized therapy for HCC. Hepatology International 2019; 13(2): 125 doi: 10.1007/s12072-018-9919-1
|
| 13 |
Seulki Lee, Minjong Lee, Jong Bin Kim, Ara Jo, Eun Ju Cho, Su Jong Yu, Jeong-Hoon Lee, Jung-Hwan Yoon, Yoon Jun Kim. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling. Biochemical and Biophysical Research Communications 2016; 473(4): 1247 doi: 10.1016/j.bbrc.2016.04.049
|
| 14 |
Liyang Dong, Xuebang Zhang, Wei Xiang, Junwei Ni, Weizhong Zhou, Haiyan Li. Post-transcription mediated Snail stabilization is involved in radiation exposure induced invasion and migration of hepatocarcinoma cells. Biomedicine & Pharmacotherapy 2018; 103: 767 doi: 10.1016/j.biopha.2018.04.095
|
| 15 |
Chou Yang, Lingyan Zhang, Xin Hao, Mengdie Tang, Bin Zhou, Jinlin Hou. Identification of a Novel N7-Methylguanosine-Related LncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma and Experiment Verification. Current Oncology 2022; 30(1): 430 doi: 10.3390/curroncol30010035
|
| 16 |
Anna La Salvia, Paula Espinosa-Olarte, Maria Del Carmen Riesco-Martinez, Beatriz Anton-Pascual, Rocío Garcia-Carbonero. Targeted Cancer Therapy: What’s New in the Field of Neuroendocrine Neoplasms?. Cancers 2021; 13(7): 1701 doi: 10.3390/cancers13071701
|
| 17 |
Changbo Fu, Xuan Xu, Weijun Lu, Lei Nie, Tao Yin, Dongde Wu. Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma. Medicine 2019; 98(42): e17412 doi: 10.1097/MD.0000000000017412
|
| 18 |
Chao Liu, Meng Zhang, Jisen Zhao, Xinshu Zhu, Ling Zhu, Mengdan Yan, Xiaoxian Zhang, Rui Zhang. LncRNA FOXD3-AS1 Mediates AKT Pathway to Promote Growth and Invasion in Hepatocellular Carcinoma Through Regulating RICTOR. Cancer Biotherapy and Radiopharmaceuticals 2020; 35(4): 292 doi: 10.1089/cbr.2019.3335
|
| 19 |
Yinghong Wang, Jin Zhang, Peng Jiang, Kai Li, Yancai Sun, Yan Huang. ASIC1a promotes acidic microenvironment-induced HCC cells migration and invasion by inducing autophagy. European Journal of Pharmacology 2021; 907: 174252 doi: 10.1016/j.ejphar.2021.174252
|
| 20 |
Mingming Sun, Xuzi Zhao, Leilei Liang, Xufeng Pan, Hao Lv, Yongfu Zhao. Sialyltransferase ST3GAL6 mediates the effect of microRNA‐26a on cell growth, migration, and invasion in hepatocellular carcinoma through the protein kinase B/mammalian target of rapamycin pathway. Cancer Science 2017; 108(2): 267 doi: 10.1111/cas.13128
|
| 21 |
Leijuan Gan, Mengran Lang, Xindi Tian, Shaohua Ren, Guangtao Li, Yayue Liu, Ruyu Han, Kangwei Zhu, Huikai Li, Qiang Wu, Yunlong Cui, Wei Zhang, Feng Fang, Qiang Li, Tianqiang Song. A Retrospective Analysis of Conversion Therapy with Lenvatinib, Sintilimab, and Arterially-Directed Therapy in Patients with Initially Unresectable Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; : 673 doi: 10.2147/JHC.S404675
|
| 22 |
Qiaoya Li, Hongyang Li, Chengjun He, Zhouhong Jing, Changan Liu, Juan Xie, Wenwen Ma, Huisheng Deng. The use of 5-fluorouracil-loaded nanobubbles combined with low-frequency ultrasound to treat hepatocellular carcinoma in nude mice. European Journal of Medical Research 2017; 22(1) doi: 10.1186/s40001-017-0291-8
|
| 23 |
JinSuo Chen, LiNa Wang, XueMei Wu, ZhiJie Ding, WenXi Cao, LeiLei Yang, YongPing Zhou, Li Xia, Zhao Song. MicroRNA-34b-5p increases chemosensitivity of hepatocellular carcinoma cells. Molecular & Cellular Toxicology 2024; doi: 10.1007/s13273-024-00431-z
|
| 24 |
Yu-Gang Wang, Tao Wang, Min Shi, Bo Zhai. Long noncoding RNA EPB41L4A-AS2 inhibits hepatocellular carcinoma development by sponging miR-301a-5p and targeting FOXL1. Journal of Experimental & Clinical Cancer Research 2019; 38(1) doi: 10.1186/s13046-019-1128-9
|
| 25 |
Pan-Quan Luo, Zheng-Hui Ye, Li-Xiang Zhang, En-Dong Song, Zhi-Jian Wei, A-Man Xu, Zhen Lu. Prognostic factors for disease-free survival in postoperative patients with hepatocellular carcinoma and construction of a nomogram model. World Journal of Clinical Cases 2022; 10(36): 13250-13263 doi: 10.12998/wjcc.v10.i36.13250
Abstract(376) |
Core Tip(490) |
Full Article(HTML)(1118)
|
Full Article (PDF)-2301K(111)
|
Full Article (Word)-1644K(25)
|
Audio-895K(2)
|
Peer-Review Report-225K(51)
|
Answering Reviewers-72K(52)
|
Times Cited (0)
|
Total Visits (4901)
|
Open
|
| 26 |
Jingwen Jiang, Zhongxi Huang, Xuewu Chen, Rongcheng Luo, Hongbin Cai, Hairu Wang, Hui Zhang, Tao Sun, Yunfang Zhang. Trifluoperazine Activates FOXO1-Related Signals to Inhibit Tumor Growth in Hepatocellular Carcinoma. DNA and Cell Biology 2017; 36(10): 813 doi: 10.1089/dna.2017.3790
|
| 27 |
Shingo Toyama, Yoshiyuki Shioyama, Hiroaki Suefuji, Makoto Shinoto, Keiji Matsumoto, Kotaro Terashima, Masaaki Hidaka, Susumu Eguchi, Kuniko Abe, Hiroyuki Irie, Yuichiro Eguchi. A case of the cirrhotic patient performed living donor liver transplantation after carbon-ion radiotherapy for hepatocellular carcinoma. International Cancer Conference Journal 2018; 7(2): 65 doi: 10.1007/s13691-018-0322-5
|
| 28 |
Joseph Asemota, Mohammed Saleh, Osato Igbinovia, Danny Burns. A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular Carcinoma. Cureus 2020; doi: 10.7759/cureus.9191
|
| 29 |
Yong-Ting Lan, Xiao-Peng Fan, Yu-Chen Fan, Jing Zhao, Kai Wang. Change in the Treg/Th17 cell imbalance in hepatocellular carcinoma patients and its clinical value. Medicine 2017; 96(32): e7704 doi: 10.1097/MD.0000000000007704
|
| 30 |
Dongxu Wang, Xu Yang, Jianzhen Lin, Yi Bai, Junyu Long, Xiaobo Yang, Samuel Seery, Haitao Zhao. Comparing the efficacy and safety of second-line therapies for advanced hepatocellular carcinoma: a network meta-analysis of phase III trials. Therapeutic Advances in Gastroenterology 2020; 13 doi: 10.1177/1756284820932483
|
| 31 |
Petter Frühling, David Stillström, Fredrik Holmquist, Anders Nilsson, Jacob Freedman. Change in tissue resistance after irreversible electroporation in liver tumors as an indicator of treatment success - A multi-center analysis with long term follow-up. European Journal of Surgical Oncology 2024; 50(9): 108508 doi: 10.1016/j.ejso.2024.108508
|
| 32 |
Qing Fan, Liang Yang, Xiaodong Zhang, Yingbo Ma, Yan Li, Lei Dong, Zhihong Zong, Xiangdong Hua, Dongming Su, Hangyu Li, Jingang Liu. Autophagy promotes metastasis and glycolysis by upregulating MCT1 expression and Wnt/β-catenin signaling pathway activation in hepatocellular carcinoma cells. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0673-y
|
| 33 |
Jinyu Zhu, Bufu Tang, Xiuling Lv, Miaomiao Meng, Qiaoyou Weng, Nannan Zhang, Jie Li, Kai Fan, Liyun Zheng, Shiji Fang, Min Xu, Jiansong Ji. Identifying Apoptosis-Related Transcriptomic Aberrations and Revealing Clinical Relevance as Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma. Frontiers in Oncology 2021; 10 doi: 10.3389/fonc.2020.519180
|
| 34 |
Faezeh Sharafi, Sadegh Abaei Hasani, Samira Alesaeidi, Mohammad Saeed Kahrizi, Ali Adili, Shadi Ghoreishizadeh, Navid Shomali, Rozita Tamjidifar, Ramin Aslaminabad, Morteza Akbari. A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02682-z
|
| 35 |
Zhiqiu Hu, Kai Jiang, Qimeng Chang, Yuhua Zhang, Bing Zhou, Ziping Zhang, Ran Tao. Effect of talin1 on apoptosis in hepatoma carcinoma cells via the PI3K/Akt/NF-κB signaling pathway. RSC Advances 2017; 7(64): 40179 doi: 10.1039/C7RA05792J
|
| 36 |
Lijun Qiao, Weibin Hu, Linzhi Li, Xin Chen, Liping Liu, Jingbo Wang. USP11 promotes glycolysis by regulating HIF‐1α stability in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine 2024; 28(2) doi: 10.1111/jcmm.18017
|
| 37 |
Joydeep Chakraborty, Eric Hilgenfeldt, Roniel Cabrera. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; : 175 doi: 10.1007/978-3-319-68082-8_10
|
| 38 |
Lei Zhang, Xuan Zhang, Zhaokun Cui, Lijuan Zhou, Kai Qu, Nannan Wang. Effects of high-quality nursing care on psychological outcomes and quality of life in patients with hepatocellular carcinoma. Medicine 2020; 99(35): e21855 doi: 10.1097/MD.0000000000021855
|
| 39 |
Shiming Yi, Chunlei Zhang, Ming Li, Jiafeng Wang, Zhongjie Shi. Construction of a Novel Diagnostic Model Based on Ferroptosis-Related Genes for Hepatocellular Carcinoma Using Machine and Deep Learning Methods. Journal of Oncology 2023; 2023: 1 doi: 10.1155/2023/1624580
|
| 40 |
Lin Zheng, Hai-Liang Li, Chen-Yang Guo, Su-Xia Luo. Comparison of the Efficacy and Prognostic Factors of Transarterial Chemoembolization Plus Microwave Ablation versus Transarterial Chemoembolization Alone in Patients with a Large Solitary or Multinodular Hepatocellular Carcinomas. Korean Journal of Radiology 2018; 19(2): 237 doi: 10.3348/kjr.2018.19.2.237
|
| 41 |
Qin Qiu, Lujuan Jiang, Hanshen Zhen, Fengyin Huang, Dandan Zhen, Meifang Ye, Xueyan Meng, Yuanyuan Liu, Xijun Qin. Promotion of HepG2 cell apoptosis by Sedum emarginatum Migo and the mechanism of action. BMC Complementary Medicine and Therapies 2022; 22(1) doi: 10.1186/s12906-022-03503-6
|
| 42 |
Xiaozhan Zhang, Zhenzhen Yan, Lei Wang, Shijie Zhang, Ming Gao. STAT1‐induced upregulation of lncRNA RHPN1‐AS1 predicts a poor prognosis of hepatocellular carcinoma and contributes to tumor progression via the miR‐485/CDCA5 axis. Journal of Cellular Biochemistry 2020; 121(12): 4741 doi: 10.1002/jcb.29689
|
| 43 |
Jianping Cao, Hanwen Chen, Wei Lu, Yihua Wu, Xia Wu, Dajing Xia, Jiang Zhu. Myricetin Induces Protective Autophagy by Inhibiting the Phosphorylation of mTOR in HepG2 Cells. The Anatomical Record 2018; 301(5): 786 doi: 10.1002/ar.23754
|
| 44 |
Jiang Liu, Chengtong Zhai, Degan Liu, Jianhua Liu, Maria Beatrice Morelli. The Long Noncoding RNA LOXL1-AS1 Promotes the Proliferation, Migration, and Invasion in Hepatocellular Carcinoma. Analytical Cellular Pathology 2020; 2020: 1 doi: 10.1155/2020/4182092
|
| 45 |
Yuan-yuan Guo, Yuan Wu, Xiao-wei Jia, Wei An. Augmenter of liver regeneration potentiates doxorubicin anticancer efficacy by reducing the expression of ABCB1 and ABCG2 in hepatocellular carcinoma. Laboratory Investigation 2017; 97(12): 1400 doi: 10.1038/labinvest.2017.72
|
| 46 |
Joseph T. Nandhini, Devaraj Ezhilarasan, Shanmugam Rajeshkumar. An ecofriendly synthesized gold nanoparticles induces cytotoxicity via apoptosis inHepG2cells. Environmental Toxicology 2021; 36(1): 24 doi: 10.1002/tox.23007
|
| 47 |
Li Li, Li Xu, Jing Yan, Zuo-Jun Zhen, Yong Ji, Chao-Qun Liu, Wan Yee Lau, Limin Zheng, Jing Xu. CXCR2–CXCL1 axis is correlated with neutrophil infiltration and predicts a poor prognosis in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0247-1
|
| 48 |
Shahid A Khan, Stephen McClements, Isabella Reccia, Joanne Evans, Madhava Pai, Rohini Sharma. The Next Generation of Hepatocellular Cancer Experts: What do They Think?. Hepatic Oncology 2016; 3(4): 213 doi: 10.2217/hep-2017-0003
|
| 49 |
Liang Zhang, Yi Huang, Junjun Ling, Wenlei Zhuo, Zhen Yu, Mengmeng Shao, Yunbo Luo, Yi Zhu. Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approaches. Cancer Biomarkers 2018; 22(3): 511 doi: 10.3233/CBM-171160
|
| 50 |
Wei Zhang, Jinzhen Cai, Bin Wu, Zhongyang Shen. pH-responsive hyaluronic acid nanoparticles coloaded with sorafenib and cisplatin for treatment of hepatocellular carcinoma. Journal of Biomaterials Applications 2019; 34(2): 219 doi: 10.1177/0885328219849711
|
| 51 |
Shu-Juan Tang, Jing-Bo Yang. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma. Molecular and Cellular Biochemistry 2020; 473(1-2): 143 doi: 10.1007/s11010-020-03815-6
|
| 52 |
Ki Joo Pahk, Goran Hamid Mohammad, Massimo Malago, Nader Saffari, Dipok Kumar Dhar. A Novel Approach to Ultrasound-Mediated Tissue Decellularization and Intra-Hepatic Cell Delivery in Rats. Ultrasound in Medicine & Biology 2016; 42(8): 1958 doi: 10.1016/j.ultrasmedbio.2016.03.020
|
| 53 |
Yuchong Peng, Weiye Leng, Shigang Duan, Ming Hong. Long noncoding RNA BLACAT1 is overexpressed in hepatocellular carcinoma and its downregulation suppressed cancer cell development through endogenously competing against hsa-miR-485-5p. Biomedicine & Pharmacotherapy 2019; 116: 109027 doi: 10.1016/j.biopha.2019.109027
|
| 54 |
Mattia Garancini, Enrico Pinotti, Stefano Nespoli, Fabrizio Romano, Luca Gianotti, Vittorio Giardini. Hepatic resection beyond barcelona clinic liver cancer indication: When and how. World Journal of Hepatology 2016; 8(11): 513-519 doi: 10.4254/wjh.v8.i11.513
|
| 55 |
Qiuming Su, Wang Li, Xibing Zhang, Ruichao Wu, Kepu Zheng, Tao Zhou, Yun Dong, Yutao He, Duo Wang, Jianghua Ran. Integrated Bioinformatics Analysis for the Screening of Hub Genes and
Therapeutic Drugs in Hepatocellular Carcinoma. Current Pharmaceutical Biotechnology 2023; 24(8): 1035 doi: 10.2174/1389201023666220628113452
|
| 56 |
Shangkun Ning, Xinge Li, Xiangyu Ma, Jibing Liu, Xu Chang. Efficacy of TACE Combined with Lenvatinib Plus Sintilimab for Hepatocellular Carcinoma with Tumor Thrombus in the Inferior Vena Cava and/or Right Atrium. Journal of Hepatocellular Carcinoma 2023; : 1511 doi: 10.2147/JHC.S410967
|
| 57 |
Kun Liu, Yuening Zhang, Chengdong Zhang, Qinle Zhang, Jiatong Li, Feifan Xiao, Yingfang Li, Ruoheng Zhang, Dongwei Dou, Jiezhen Liang, Jian Qin, Zhidi Lin, Dong Zhao, Min Jiang, Zhenxin Liang, Jie Su, Vanaparthy Pranay Gupta, Min He, Xiaoli Yang. Methylation of S100A8 is a promising diagnosis and prognostic marker in hepatocellular carcinoma. Oncotarget 2016; 7(35): 56798 doi: 10.18632/oncotarget.10792
|
| 58 |
Hyunsoo Kim, JiYoung Park, Yongkang Kim, Areum Sohn, Injun Yeo, Su Jong Yu, Jung-Hwan Yoon, Taesung Park, Youngsoo Kim. Serum fibronectin distinguishes the early stages of hepatocellular carcinoma. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-09691-3
|
| 59 |
Haoxiang Wen, Ruiming Liang, Xiaofei Liu, Yang Yu, Shuirong Lin, Zimin Song, Yihao Huang, Xi Yu, Shuling Chen, Lili Chen, Baifeng Qian, Jingxian Shen, Han Xiao, Shunli Shen. Predicting Pathological Response of Neoadjuvant Conversion Therapy for Hepatocellular Carcinoma Patients Using CT-Based Radiomics Model. Journal of Hepatocellular Carcinoma 2024; : 2145 doi: 10.2147/JHC.S487370
|
| 60 |
Jiatian Lin, Jiyin Ruan, Hao Zhu, Zaizhong Chen, Junhui Chen, Hongjian Yu. Tenacissoside H Induces Autophagy and Radiosensitivity of Hepatocellular Carcinoma Cells by PI3K/Akt/mTOR Signaling Pathway. Dose-Response 2021; 19(2) doi: 10.1177/15593258211011023
|
| 61 |
Xili Jiang, Wei Zhang, Lifeng Li, Shucai Xie. Integrated Transcriptomic Analysis Revealed Hub Genes and Pathways Involved in Sorafenib Resistance in Hepatocellular Carcinoma. Pathology and Oncology Research 2021; 27 doi: 10.3389/pore.2021.1609985
|
| 62 |
Lei Fang, Minchang Feng, Feihong Chen, Xia Liu, Hong Shen, Jian Zhao, Shaohua Gou. Oleanolic acid-NO donor-platinum(II) trihybrid molecules: Targeting cytotoxicity on hepatoma cells with combined action mode and good safety. Bioorganic & Medicinal Chemistry 2016; 24(19): 4611 doi: 10.1016/j.bmc.2016.07.066
|
| 63 |
Gyeong Eun Hong, Ho Jeong Lee, Jin A. Kim, Silvia Yumnam, Suchismita Raha, Venu Venkatarame Gowda Saralamma, Jeong Doo Heo, Sang Joon Lee, Eun Hee Kim, Chun Kil Won, Gon Sup Kim. Korean Byungkyul - Citrus platymamma Hort.et Tanaka flavonoids induces cell cycle arrest and apoptosis, regulating MMP protein expression in Hep3B hepatocellular carcinoma cells. International Journal of Oncology 2017; 50(2): 575 doi: 10.3892/ijo.2016.3816
|
| 64 |
Ya-yun Qian, Wen-yuan Li, Yan Yan, Xue-yu Zhao, Ting Yang, Chuan-ci Fang, Jing-jing Hou, Yan-qing Liu. Celastrus orbiculatus Extracts Inhibit Human Hepatocellular Carcinoma Growth by Targeting mTOR Signaling Pathways. Chinese Journal of Integrative Medicine 2019; 25(11): 845 doi: 10.1007/s11655-019-3035-5
|
| 65 |
Jiahui Zhao, Rongjun He, Hao Zhong, Shizhu Liu, Xiaofeng Liu, Muhammad Hussain, Peilong Sun. A cold-water extracted polysaccharide-protein complex from Grifola frondosa exhibited anti-tumor activity via TLR4-NF-κB signaling activation and gut microbiota modification in H22 tumor-bearing mice. International Journal of Biological Macromolecules 2023; 239: 124291 doi: 10.1016/j.ijbiomac.2023.124291
|
| 66 |
Azemat Jamshidi-Parsian, Robert J. Griffin, Rajshekhar A. Kore, Valentina K. Todorova, Issam Makhoul. Tumor-endothelial cell interaction in an experimental model of human hepatocellular carcinoma. Experimental Cell Research 2018; 372(1): 16 doi: 10.1016/j.yexcr.2018.09.001
|
| 67 |
Changku Jia, Ke Ge, Sunbing Xu, Ling Liu, Jie Weng, Youke Chen. Selective occlusion of the hepatic artery and portal vein improves liver hypertrophy for staged hepatectomy. World Journal of Surgical Oncology 2019; 17(1) doi: 10.1186/s12957-019-1710-9
|
| 68 |
Zhongqiang Qin, Fangquan Zhu, Bo Xie, Yang Zhang, Mu Yuan, Peipei Yang, Lan Zhang, Jianzhu Wei, Ziyi Zhu, Zhen Qian, Zhaoying Wang, Longfei Fan, Shuaishuai Xu, Yulin Tan, Jingyu Qian. Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinoma. Translational Oncology 2024; 39: 101816 doi: 10.1016/j.tranon.2023.101816
|
| 69 |
Hao Cai, Bo‑Gen Ye, Jian‑Yang Ao, Xiao‑Dong Zhu, Yuan‑Yuan Zhang, Zong‑Tao Chai, Cheng‑Hao Wang, Hui‑Chuan Sun. High expression of S100A12 on intratumoral stroma cells indicates poor prognosis following surgical resection of hepatocellular carcinoma. Oncology Letters 2018; doi: 10.3892/ol.2018.9270
|
| 70 |
Chaozhi Tang, Jiakang Ma, Xiuli Liu, Zhengchun Liu. Identification of a prognostic signature of nine metabolism-related genes for hepatocellular carcinoma. PeerJ 2020; 8: e9774 doi: 10.7717/peerj.9774
|
| 71 |
Huating Wu, Dawei Xie, Yingxia Yang, Qing Yang, Xiajun Shi, Rong Yang. Ultrasound-Targeted Microbubble Destruction-Mediated miR-206 Overexpression Promotes Apoptosis and Inhibits Metastasis of Hepatocellular Carcinoma Cells Via Targeting PPIB. Technology in Cancer Research & Treatment 2020; 19 doi: 10.1177/1533033820959355
|
| 72 |
Wei Lin, Zhiguang Zhao, Zhonglin Ni, Yaxin Zhao, Wenjun Du, Shijun Chen. IFI16 restoration in hepatocellular carcinoma induces tumour inhibition via activation of p53 signals and inflammasome. Cell Proliferation 2017; 50(6) doi: 10.1111/cpr.12392
|
| 73 |
Ying-Chun Hu, Zhu-Jun Yi, Yun Zhou, Pei-Zhi Li, Zuo-Jin Liu, Shi-Gang Duan, Jian-Ping Gong. Overexpression of RIP140 suppresses the malignant potential of hepatocellular carcinoma by inhibiting NF-κB-mediated alternative polarization of macrophages. Oncology Reports 2017; 37(5): 2971 doi: 10.3892/or.2017.5551
|
| 74 |
Hengyu Tian, Yuanyuan Chen, Renjie Zhang, Jialin Liu. The Role of COL22A1 in the Pathophysiology of Hepatocellular Carcinoma: Evidence from Bioinformatics Exploration. Cancer Management and Research 2022; : 739 doi: 10.2147/CMAR.S349991
|
| 75 |
Li Yin, Cuifang Chang, Cunshuan Xu. G2/M checkpoint plays a vital role at the early stage of HCC by analysis of key pathways and genes. Oncotarget 2017; 8(44): 76305 doi: 10.18632/oncotarget.19351
|
| 76 |
Yongbiao Huang, Shanshan Huang, Li Ma, Yali Wang, Xi Wang, Lingyan Xiao, Wan Qin, Long Li, Xianglin Yuan. Exploring the Prognostic Value, Immune Implication and Biological Function of H2AFY Gene in Hepatocellular Carcinoma. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.723293
|
| 77 |
Adriana Fontes, Mireia Alemany-Pagès, Paulo J. Oliveira, João Ramalho-Santos, Hans Zischka, Anabela Marisa Azul. Antioxidant Versus Pro-Apoptotic Effects of Mushroom-Enriched Diets on Mitochondria in Liver Disease. International Journal of Molecular Sciences 2019; 20(16): 3987 doi: 10.3390/ijms20163987
|
| 78 |
Chandramohan Kiruthiga, Kasi Pandima Devi, Seyed M. Nabavi, Anupam Bishayee. Autophagy: A Potential Therapeutic Target of Polyphenols in Hepatocellular Carcinoma. Cancers 2020; 12(3): 562 doi: 10.3390/cancers12030562
|
| 79 |
Huancheng Wang, Jia Liu. Exploration of Sorafenib Influences on Gene Expression of Hepatocellular Carcinoma. Frontiers in Genetics 2020; 11 doi: 10.3389/fgene.2020.577000
|
| 80 |
Chen Li, Lu Lu, Bing Feng, Kai Zhang, Siqi Han, Daorong Hou, Longbang Chen, Xiaoyuan Chu, Rui Wang. RETRACTED ARTICLE: The lincRNA-ROR/miR-145 axis promotes invasion and metastasis in hepatocellular carcinoma via induction of epithelial-mesenchymal transition by targeting ZEB2. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04113-w
|
| 81 |
Kun-peng Fang, Wei Dai, Yan-Hong Ren, Ye-Chuan Xu, She-min Zhang, Ye-Ben Qian. Both Talin-1 and Talin-2 correlate with malignancy potential of the human hepatocellular carcinoma MHCC-97 L cell. BMC Cancer 2016; 16(1) doi: 10.1186/s12885-016-2076-9
|
| 82 |
Qianhui Chen, Xinyu Lu, Jiayi Xie, Na Ma, Weikang Xu, Zhiming Zhang, Xuan Huang, Hongyan Liu, Jinlin Hou, Xiaoyong Zhang, Wei Zhu. Analysis of L Antigen Family Member 3 as a Potential Biomarker and Therapeutic Target Associated With the Progression of Hepatocellular Carcinoma. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.813275
|
| 83 |
Masafumi Ikeda, Masahiro Kobayashi, Makoto Tahara, Shuichi Kaneko. Optimal management of patients with hepatocellular carcinoma treated with lenvatinib. Expert Opinion on Drug Safety 2018; 17(11): 1095 doi: 10.1080/14740338.2018.1530212
|
| 84 |
Zhizhong Ren, Yuanxun Yue, Yuewei Zhang, Jiahong Dong, Ying Liu, Xiaowei Yang, Xin Lin, Xueqiang Zhao, Zhanqi Wei, Yu Zheng, Tianxiao Wang. Changes in the Peripheral Blood Treg Cell Proportion in Hepatocellular Carcinoma Patients After Transarterial Chemoembolization With Microparticles. Frontiers in Immunology 2021; 12 doi: 10.3389/fimmu.2021.624789
|
| 85 |
Min Zhu, Xiujing Liu, Changhui Zhou, Juan Li. Effect of sodium cantharidinate/vitamin B6 injection on survival, liver function, immune function, and quality of life in patients with hepatocellular carcinoma. Medicine 2020; 99(34): e21952 doi: 10.1097/MD.0000000000021952
|
| 86 |
Raymond Wu, Ramachandran Murali, Yasuaki Kabe, Samuel W. French, Yi‐Ming Chiang, Siyu Liu, Linda Sher, Clay C. Wang, Stan Louie, Hidekazu Tsukamoto. Baicalein Targets GTPase‐Mediated Autophagy to Eliminate Liver Tumor–Initiating Stem Cell–Like Cells Resistant to mTORC1 Inhibition. Hepatology 2018; 68(5): 1726 doi: 10.1002/hep.30071
|
| 87 |
Zhiwen Jiang, Shuning Wang, Jun Hou, Jinhua Chi, Shuo Wang, Kai Shao, Wanshun Liu, Rongju Sun, Baoqin Han. Effects of carboxymethyl chitosan oligosaccharide on regulating immunologic function and inhibiting tumor growth. Carbohydrate Polymers 2020; 250: 116994 doi: 10.1016/j.carbpol.2020.116994
|
| 88 |
Riccardo Lencioni, Filip Braet. Novel Transarterial Biomimetic-Based Nanoparticles for the Treatment of Hepatocellular Carcinoma. Gastroenterology 2016; 150(2): 312 doi: 10.1053/j.gastro.2015.12.022
|
| 89 |
Sindhia Kumari, Arslan Ali, Talat Roome, Anam Razzak, Ayesha Iqbal, Amna Jabbar Siddiqui, Syed Muhammad Zahid Azam, Hafeezullah Shaikh, Hesham R. El-Seedi, Syed Ghulam Musharraf. Metabolomics approach to understand the hepatitis C virus induced hepatocellular carcinoma using LC-ESI-MS/MS. Arabian Journal of Chemistry 2021; 14(1): 102907 doi: 10.1016/j.arabjc.2020.11.013
|
| 90 |
Gang Xu, Shanshan Bu, Xiushen Wang, Hong Ge. Silencing the Expression of Cyclin G1 Enhances the Radiosensitivity of Hepatocellular Carcinoma In Vitro and In Vivo by Inducing Apoptosis. Radiation Research 2021; 195(4) doi: 10.1667/RADE-20-00180.1
|
| 91 |
Ning Zhang, Hui Li, Chengdong Qin, Dening Ma, Yiming Zhao, Weiping Zhu, Lu Wang. Insufficient radiofrequency ablation promotes the metastasis of residual hepatocellular carcinoma cells via upregulating flotillin proteins. Journal of Cancer Research and Clinical Oncology 2019; 145(4): 895 doi: 10.1007/s00432-019-02852-z
|
| 92 |
Yang Li, Dan-Yun Ruan, Chang-Chang Jia, Hui Zhao, Guo-Ying Wang, Yang Yang, Nan Jiang. Surgical resection versus liver transplantation for hepatocellular carcinoma within the Hangzhou criteria: a preoperative nomogram-guided treatment strategy. Hepatobiliary & Pancreatic Diseases International 2017; 16(5): 480 doi: 10.1016/S1499-3872(17)60052-3
|
| 93 |
Chen-Yi Liao, Ching-Chang Lee, Chi-chang Tsai, Chao-Wen Hsueh, Chih-Chiang Wang, I-Hung Chen, Ming-Kai Tsai, Mei-Yu Liu, An-Tie Hsieh, Kuan-Jen Su, Hau-Ming Wu, Shih-Chung Huang, Yi-Chen Wang, Chien-Yao Wang, Shu-Fang Huang, Yen-Cheng Yeh, Ren-Jy Ben, Shang-Tao Chien, Chin-Wen Hsu, Wu-Hsien Kuo. Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular Carcinoma. BioMed Research International 2015; 2015: 1 doi: 10.1155/2015/840542
|
| 94 |
Zhongwei Xu, Jun Bao, Xiaohan Jin, Heng Li, Kaiyuan Fan, Zhidong Wu, Min Yao, Yan Zhang, Gang Liu, Dan Wang, Xiaoping Yu, Jia Guo, Ruicheng Xu, Qian Gong, Fengmei Wang, Jin Wang. The Effects of Cinobufagin on Hepatocellular Carcinoma Cells Enhanced by MRT68921, an Autophagy Inhibitor. The American Journal of Chinese Medicine 2023; 51(06): 1595 doi: 10.1142/S0192415X23500726
|
| 95 |
Jella-Andrea Abraham, Kristina Yeghiazaryan, Olga Golubnitschaja. Selective internal radiation therapy in treatment of hepatocellular carcinoma: new concepts of personalization. Personalized Medicine 2016; 13(4): 347 doi: 10.2217/pme-2016-0014
|
| 96 |
Ilaria Grossi, Bruna Arici, Nazario Portolani, Giuseppina De Petro, Alessandro Salvi. Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma. Oncotarget 2017; 8(4): 6955 doi: 10.18632/oncotarget.14332
|
| 97 |
Jinrong Lou, Yong Li, Kangning Liang, Yutian Guo, Changlong Song, Lei Chen, Lifang Wang, Fei Wang, Li Zhang, Xia Chen, Xiangdong Xu, Mianshun Pan. Hypofractionated radiotherapy as a salvage treatment for recurrent hepatocellular carcinoma with inferior vena cava/right atrium tumor thrombus: a multi-center analysis. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5870-3
|
| 98 |
Shiyang Zheng, Yan Guo, Lizhen Dai, Ziming Liang, Qing Yang, Shuhong Yi. Long intergenic noncoding RNA01134 accelerates hepatocellular carcinoma progression by sponging microRNA-4784 and downregulating structure specific recognition protein 1. Bioengineered 2020; 11(1): 1016 doi: 10.1080/21655979.2020.1818508
|
| 99 |
Abhishek Kumar, Olivier Moralès, Serge Mordon, Nadira Delhem, Emmanuel Boleslawski. Could Photodynamic Therapy Be a Promising Therapeutic Modality in Hepatocellular Carcinoma Patients? A Critical Review of Experimental and Clinical Studies. Cancers 2021; 13(20): 5176 doi: 10.3390/cancers13205176
|
| 100 |
Xiaonan Li, Yongsheng Zhang, Wei Ma, Jingwen Li, Hui Yu. An Elevated Neutrophil-to-Lymphocyte Ratio Predicts Poor Prognosis in Patients with Liver Cancer after Interventional Treatments. BioMed Research International 2022; 2022: 1 doi: 10.1155/2022/6141317
|
| 101 |
Jie Mao, Hongbao Yang, Tingting Cui, Pan Pan, Nadia Kabir, Duo Chen, Jinyan Ma, Xingyi Chen, Yijun Chen, Yong Yang. Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3/ERK/AKT. European Journal of Pharmacology 2018; 832: 39 doi: 10.1016/j.ejphar.2018.05.027
|
| 102 |
Yuan Zhang, Min Ding, Jia-chang Chi, Tao Wang, Yao-ping Shi, Bo Zhai. The early evaluation of ultrasound-guided iodine-125 interstitial implants for high-risk hepatocellular carcinoma. Brachytherapy 2019; 18(5): 733 doi: 10.1016/j.brachy.2019.05.011
|
| 103 |
Yuan He, Yingying Lin, Fei He, Lijuan Shao, Wei Ma, Fei He. Role for calcium‐activated potassium channels (BK) in migration control of human hepatocellular carcinoma cells. Journal of Cellular and Molecular Medicine 2021; 25(20): 9685 doi: 10.1111/jcmm.16918
|
| 104 |
Jin Li, Yi Xu, Shu-De Tan, Zhi Wang. Impact of red blood cell distribution width (RDW) on postoperative outcomes in hepatocellular carcinoma (HCC) patients. Medicine 2024; 103(24): e38475 doi: 10.1097/MD.0000000000038475
|
| 105 |
Yinghong Wang, Hong Zhou, Yancai Sun, Yan Huang. Acid-sensing ion channel 1: potential therapeutic target for tumor. Biomedicine & Pharmacotherapy 2022; 155: 113835 doi: 10.1016/j.biopha.2022.113835
|
| 106 |
Jasmine Baby, Aswathy R. Devan, Ayana R. Kumar, Jaggaiah N. Gorantla, Bhagyalakshmi Nair, Thanatharayil Sathian Aishwarya, Lekshmi R. Nath. Cogent role of flavonoids as key orchestrators of chemoprevention of hepatocellular carcinoma: A review. Journal of Food Biochemistry 2021; 45(7) doi: 10.1111/jfbc.13761
|
| 107 |
Zhiqiang Qin, Xinjuan Yu, Mei Lin, Jinkun Wu, Shupei Ma, Ning Wang. Prognostic and clinicopathological value of Beclin-1 expression in hepatocellular carcinoma: a meta-analysis. World Journal of Surgical Oncology 2018; 16(1) doi: 10.1186/s12957-018-1465-8
|
| 108 |
Chuandong Zhu, Lixue Wang, Yang Cai, Guoxiang Wang, Hanfeng Xu, Yuan Wan, Qin Zheng. Enhanced radiation effect on SMCC7721 cells through endoplasmic reticulum stress induced by C225-GNPs in�vitro and in�vivo. Oncology Letters 2018; doi: 10.3892/ol.2018.7864
|
| 109 |
Yinglian Li, Yuan Fang, DongLi Li, Jiangtao Wu, Zichong Huang, Xueyin Liao, Xuemei Liu, Chunxiao Wei, Zhong Huang. Constructing a prognostic model for hepatocellular carcinoma based on bioinformatics analysis of inflammation-related genes. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1420353
|
| 110 |
Teng Zhao, Longjiu Cui, Aijun Li. The significance of RDW in patients with hepatocellular carcinoma after radical resection. Cancer Biomarkers 2016; 16(4): 507 doi: 10.3233/CBM-160591
|
| 111 |
Junjie Liang, Nan Yao, Bo Deng, Jinying Li, Yuchuan Jiang, Tongzheng Liu, Youzhu Hu, Mingrong Cao, Jian Hong. GINS1 promotes ZEB1‐mediated epithelial‐mesenchymal transition and tumor metastasis via β‐catenin signaling in hepatocellular carcinoma. Journal of Cellular Physiology 2024; 239(5) doi: 10.1002/jcp.31237
|
| 112 |
Feng‑Tao Yi, Qi‑Ping Lu. Mucin 1 promotes radioresistance in hepatocellular carcinoma cells through activation of JAK2/STAT3 signaling. Oncology Letters 2017; doi: 10.3892/ol.2017.7119
|
| 113 |
Jorge A. Marrero, Masatoshi Kudo, Alan P. Venook, Sheng-Long Ye, Jean-Pierre Bronowicki, Xiao-Ping Chen, Lucy Dagher, Junji Furuse, Jean-Francois H. Geschwind, Laura Ladrón de Guevara, Christos Papandreou, Tadatoshi Takayama, Arun J. Sanyal, Seung Kew Yoon, Keiko Nakajima, Robert Lehr, Stephanie Heldner, Riccardo Lencioni. Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study. Journal of Hepatology 2016; 65(6): 1140 doi: 10.1016/j.jhep.2016.07.020
|
| 114 |
Yuxiang Wan, Honglin Jiang, Zeyu Liu, Chen Bai, Yanyan Lian, Chunguang Zhang, Qiaoli Zhang, Jinchang Huang. Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic
Reprogramming of Hepatocellular Carcinoma: A Study based on Network
Pharmacology, Molecular Docking and Bioinformatics. Current Pharmaceutical Design 2024; 30(24): 1894 doi: 10.2174/0113816128287535240429043610
|
| 115 |
Chao He, Tingting Wu, Yongqiang Hao. Anlotinib induces hepatocellular carcinoma apoptosis and inhibits proliferation via Erk and Akt pathway. Biochemical and Biophysical Research Communications 2018; 503(4): 3093 doi: 10.1016/j.bbrc.2018.08.098
|
| 116 |
Nicole Cheng, Nathanelle Khoo, Alexander Y. F. Chung, Brian K. P. Goh, Peng Chung Cheow, Pierce K. H. Chow, Ser Yee Lee, London L. Ooi, Prema Raj Jeyaraj, Juinn Huar Kam, Ye Xin Koh, Chung Yip Chan, Jin Yao Teo. Pre‐operative Imaging Characteristics in Histology‐Proven Resected Intrahepatic Cholangiocarcinoma. World Journal of Surgery 2020; 44(11): 3862 doi: 10.1007/s00268-020-05698-6
|
| 117 |
Disha D. Shah, Bhavarth P. Dave, Parv A. Patel, Mehul R. Chorawala, Vishvas N. Patel, Palak A. Shah, Manish P. Patel. Revamping the innate or innate-like immune cell-based therapy for hepatocellular carcinoma: new mechanistic insights and advanced opportunities. Medical Oncology 2023; 40(2) doi: 10.1007/s12032-023-01948-4
|
| 118 |
Weitong Sun, Yong Wang, Mingyue Cai, Liteng Lin, Xiaoyan Chen, Zhong Cao, Kangshun Zhu, Xintao Shuai. Codelivery of sorafenib and GPC3 siRNA with PEI-modified liposomes for hepatoma therapy. Biomaterials Science 2017; 5(12): 2468 doi: 10.1039/C7BM00866J
|
| 119 |
Ren-Yi Su, Sun-Bin Ling, Qiao-Nan Shan, Xu-Yong Wei, Rui Wang, Chang-Ku Jia, Li Zhuang, Tian Shen, Li-Min Ding, Zhi-Dan Xu, Lai-Bang Luo, Li-Bo Sun, Guang-Ming Li, Tai-Shi Fang, Nan Jiang, Kun Zhang, Zhao-Jie Su, Zhi-Hai Peng, Ren Lang, Tao Jiang, Qiang He, Lin-Sen Ye, Yang Yang, Yu-Ting He, Wen-Zhi Guo, Liu-Gen Lan, Xu-Yong Sun, Dong Chen, Zhi-Shui Chen, Da-Wei Zhou, Shao-Jun Ye, Qi-Fa Ye, Min Tian, Jian-Hua Shi, Bo Wang, Jiang Liu, Qian Lu, Wei Rao, Jin-Zhen Cai, Tao Lv, Jia-Yin Yang, Pu-Sen Wang, Lin Zhong, Jing-Sheng Ma, Qi-Gen Li, Sheng-Dong Wu, Chang-Jiang Lu, Cai-De Lu, Dong-Hua Zhang, Xuan Wang, Zi-Qiang Li, Mu-Jian Teng, Jun-Jie Li, Wen-Tao Jiang, Jian-Hua Li, Quan-Bao Zhang, Ning-Qi Zhu, Zheng-Xin Wang, Kang He, Qiang Xia, Shao-Hua Song, Zhi-Ren Fu, Wei Qiu, Guo-Yue Lv, Rui-Peng Song, Ji-Zhou Wang, Zheng Wang, Jian Zhou, Gang Chen, Ying-Peng Zhao, Li Li, Ze-Min Hu, Qi-Jie Luo, Zhong-Zhou Si, Bin Xie, Xiao-Shun He, Zhi-Yong Guo, Shu-Sen Zheng, Xiao Xu. Efficacy and safety of sirolimus early conversion protocol in liver transplant patients with hepatocellular carcinoma: A single-arm, multicenter, prospective study. Hepatobiliary & Pancreatic Diseases International 2022; 21(2): 106 doi: 10.1016/j.hbpd.2021.09.001
|
| 120 |
Shengnan Zhao, Aixia Chen, Jingyu Cao, Zusen Wang, Weiyu Hu, Fei Zhou, Donghai Liang, Hongsheng Yu. Neurotrophin 3 hinders the growth and metastasis of hepatocellular carcinoma cells*. Oncology and Translational Medicine 2020; 6(4): 143 doi: 10.1007/s10330-020-0426-6
|
| 121 |
Michela Asperti, Luca Cantamessa, Simone Ghidinelli, Magdalena Gryzik, Andrea Denardo, Arianna Giacomini, Giovanna Longhi, Alessandro Fanzani, Paolo Arosio, Maura Poli. The Antitumor Didox Acts as an Iron Chelator in Hepatocellular Carcinoma Cells. Pharmaceuticals 2019; 12(3): 129 doi: 10.3390/ph12030129
|
| 122 |
Rodolfo Sacco, Michela Antonucci, Giampaolo Bresci, Ambra Corti, Luca Giacomelli, Valeria Mismas, Maurizio Rainieri, Antonio Romano, Roberto Eggenhoffner, Emanuele Tumino, Giuseppe Cabibbo. Curative therapies for hepatocellular carcinoma: an update and perspectives. Expert Review of Anticancer Therapy 2016; 16(2): 169 doi: 10.1586/14737140.2016.1123625
|
| 123 |
Kun You, Peisheng Sun, Zhongyi Yue, Jian Li, Wancheng Xiong, Jianguo Wang. NOR1 promotes hepatocellular carcinoma cell proliferation and migration through modulating the Notch signaling pathway. Experimental Cell Research 2017; 352(2): 375 doi: 10.1016/j.yexcr.2017.02.032
|
| 124 |
Federica Tonon, Rossella Farra, Cristina Zennaro, Gabriele Pozzato, Nhung Truong, Salvatore Parisi, Flavio Rizzolio, Mario Grassi, Bruna Scaggiante, Fabrizio Zanconati, Deborah Bonazza, Gabriele Grassi, Barbara Dapas. Xenograft Zebrafish Models for the Development of Novel Anti-Hepatocellular Carcinoma Molecules. Pharmaceuticals 2021; 14(8): 803 doi: 10.3390/ph14080803
|
| 125 |
Jiangwei Liu, Xiaocheng Li, Jianzhao Huang, Yan Liu. Matrix metalloproteinase 2 knockdown suppresses the proliferation of HepG2 and Huh7 cells and enhances the cisplatin effect. Open Medicine 2019; 14(1): 384 doi: 10.1515/med-2019-0039
|
| 126 |
Changhong Yi, Wei Wei, Maolin Wan, Ya Chen, Bo Zhang, Wenze Wu. Expression Patterns of HOX Gene Family Defines Tumor Microenvironment and Immunotherapy in Hepatocellular Carcinoma. Applied Biochemistry and Biotechnology 2023; 195(8): 5072 doi: 10.1007/s12010-023-04443-8
|
| 127 |
Lumin Chen, Jihong Sun, Xiaoming Yang. Radiofrequency ablation-combined multimodel therapies for hepatocellular carcinoma: Current status. Cancer Letters 2016; 370(1): 78 doi: 10.1016/j.canlet.2015.09.020
|
| 128 |
Susanne Smolka, Julius Chapiro, Wilfred Manzano, John Treilhard, Eric Reiner, Yanhong Deng, Yan Zhao, Bernd Hamm, James S. Duncan, Bernhard Gebauer, MingDe Lin, Jean-François Geschwind. The impact of antiangiogenic therapy combined with Transarterial Chemoembolization on enhancement based quantitative tumor response assessment in patients with hepatocellular carcinoma. Clinical Imaging 2017; 46: 1 doi: 10.1016/j.clinimag.2017.05.007
|
| 129 |
Xiaoning He, Jing Wu, Anke-Peggy Holtorf, Harald Rinde, Shuangshuang Xie, Wen Shen, Jiancun Hou, Xuehua Li, Ziping Li, Jiaming Lai, Yuting Wang, Lin Zhang, Jian Wang, Xuesong Li, Kuansheng Ma, Feng Ye, Han Ouyang, Hong Zhao, Do Young Kim. Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China. PLOS ONE 2018; 13(1): e0191095 doi: 10.1371/journal.pone.0191095
|